deltatrials
Completed NA NCT00375414

Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy

New Introducer PEG-Gastropexy Does Not Need Prophylactic Antibiotics: Prospective Randomised Double Blind Placebo Controlled Trial

Sponsor: Bethanien Krankenhaus gGmbH

Conditions Head and Neck Neoplasms Wound Infection
Interventions PEG-Gastropexy
Updated 5 times since 2017 Last updated: May 4, 2007 Started: Oct 31, 2003 Completion: Apr 30, 2007

This NA trial investigates Head and Neck Neoplasms and Wound Infection and is currently completed. Bethanien Krankenhaus gGmbH leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bethanien Krankenhaus gGmbH
  • Johann Wolfgang Goethe University Hospital
Data source: Johann Wolfgang Goethe University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Frankfurt am Main, Germany